Regulatory Developments July 2019

03a_RegNews_Alternate_770x2953.jpg

FDA guidance announcements on Product Postmarketing Safety Reporting Compliance, Postapproval Pregnancy Safety Studies, Oncology Pharmaceuticals/Reproductive Toxicity Testing and Labeling, and more.

Related Stories

Table of Contents
Regulatory Developments
July 2019